Investor Information

Company Overview

Immune Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases.

Corporate Presentation

Corporate Presentation

Download Corporate Presentation

Stock Information

Latest Financial Results

Q3 2018

Quarter Ended Sep 30, 2018

Latest Annual Filing

Fiscal Year Ended December 31, 2017

View Filing

Investor Contact Information


Immune Pharmaceuticals, Inc.
1 Bridge Plaza N
Suite 270
Fort Lee, NJ 07024
T: 201-464-2677
F: 201-608-5103
[javascript protected email address]

Investor Relations

[javascript protected email address]

Transfer Agent

V Stock Transfer, LLC
Allison Niccolls
18 Lafayette Place
Woodmere, NY 11598
T: 212-828-8436
[javascript protected email address]


Having accumulated decades of collective experience across a variety of fields, our leadership team is the source of our success.

Email Alerts

Stay informed and receive company updates straight to your inbox

Sign up today

Market Data copyright © 2019 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.